Search
N-6022
go.drugbank.com/drugs/DB12206InvestigationalN6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.
LY-2608204
go.drugbank.com/drugs/DB12284InvestigationalLY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Evocalcet
go.drugbank.com/drugs/DB12388InvestigationalEvocalcet has been used in trials studying the treatment of Hyperparathyroidism and Secondary Hyperparathyroidism.
MK-3207
go.drugbank.com/drugs/DB12424InvestigationalMk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders.
Netivudine
go.drugbank.com/drugs/DB12606InvestigationalNetivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.
Batefenterol
go.drugbank.com/drugs/DB12526InvestigationalBatefenterol has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.
SR-9011
go.drugbank.com/drugs/DB14014ExperimentalSR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues
Synonyms: 1-Pyrrolidinecarboxamide, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-n-pentyl-ZYCOV-D
go.drugbank.com/drugs/DB15892ExperimentalAs of August, 2020 the candidate is in Phase II clinical trials[A219758]. … The ZYCOV-D vaccine candidate was developed by Cadila Healthcare Ltd. based in India[A219758].
Furvina
go.drugbank.com/drugs/DB16547ExperimentalFurvina is marketed in Cuba as Dermofural®, an ointment containing G1 as the only active principle ingredient. It is used to treat dermatological infections.[A228063] … Furvina (G1) is an antimicrobial agent active against Gram-positive and Gram-negative bacteria, yeasts, and filamentous fungi.
Phosphonothreonine
go.drugbank.com/drugs/DB02482ExperimentalUsed as an identifier in the analysis of peptides, proteins, and enzymes. [PubChem]